Background How clinicians treat patients with terminal dyspnea widely varies, which could
hamper quality care. We visualized comprehensive pharmacological treatment delivered by …

Context How physicians use opioids for dyspnea in imminently dying cancer patients
(terminal dyspnea) varies markedly, which could hamper quality care. Objectives To …

Purpose Parenteral morphine is widely used for dyspnea of imminently dying cancer
patients, but the outcomes to expect over time remain largely unknown. We examined …

Dyspnea is a subjective, yet complex experience of breath-lessness, even in the absence of
overt hypoxia. Although the pathophysiology of dyspnea is not fully understood …

PURPOSE To provide guidance on the clinical management of dyspnea in adult patients
with advanced cancer. METHODS ASCO convened an Expert Panel to review the evidence …

Dyspnea in cancer patients can lead to significant deleterious effects. There are multiple
conditions that can cause dyspnea. It is important to determine which of these causes are …

Opinion statement Dyspnea is one of the most frequent and distressing symptoms in patients
with advanced cancer. As dyspnea deteriorates patients' quality of life markedly and tends to …

Dyspnea is a symptom commonly experienced by cancer patients that causes significant
suffering, worsens throughout a patient's disease trajectory, and can be more difficult to …

Background Dyspnea is a common and distressing symptom in patients with cancer. To
improve its management, multicenter confirmatory studies are necessary. Research policy …

Objectives: To evaluate the efficacy of a brief tailored non-pharmacological intervention
comprising breathing retraining and psychosocial support for managing dyspnea in cancer …